Altium Capital Management LP Olema Pharmaceuticals, Inc. Transaction History

Altium Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$10.95 - $16.62 $2.1 Million - $3.18 Million	191,393 Added 46.27%	605,000 $6.85 Million
Q4 2023 Feb 14, 2024	BUY	$10.53 - $17.14 $827,731 - $1.35 Million	78,607 Added 23.46%	413,607 $5.8 Million
Q3 2023 Nov 14, 2023	BUY	$8.19 - $12.98 $204,750 - $324,500	25,000 Added 8.06%	335,000 $4.14 Million
Q2 2023 Aug 14, 2023	BUY	$3.22 - $9.65 $998,200 - $2.99 Million	310,000 New	310,000 $2.8 Million

145

58.3M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $248M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.